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Abstract: 
The twin arginine translocation (TAT) system ferries folded proteins across the bacterial membrane. Proteins are directed 
into this system by the TAT signal peptide present at the amino terminus of the precursor protein, which contains the twin 
arginine residues that give the system its name. There are currently only two computational methods for the prediction of 
TAT translocated proteins from sequence. Both methods have limitations that make the creation of a new algorithm for 
TAT-translocated protein prediction desirable. We have developed TATPred, a new sequence-model method, based on a 
Naïve-Bayesian network, for the prediction of TAT signal peptides. In this approach, a comprehensive range of models was 
tested to identify the most reliable and robust predictor. The best model comprised 12 residues: three residues prior to the 
twin arginines and the seven residues that follow them. We found a prediction sensitivity of 0.979 and a specificity of 0.942. 
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Background: 
The bacterial Sec-independent protein export pathway is also 
known as the TAT system: since precursor proteins are 
targeted to it by a signal peptide containing a characteristic 
sequence motif comprising two consecutive arginine residues. 
The most remarkable feature of the TAT pathway is the 
apparent transportation of fully folded proteins across the 
cytoplasmic membrane without rendering the membrane 
permeable to ions. [1] Most substrates secreted via the TAT 
pathway are proteins that bind cofactors within the cytoplasm, 
and must therefore be folded before export. Such proteins 
function predominantly in respiratory and photosynthetic 
electron transfer, and are a critical component of bacterial 
energy metabolism. Proteins without cofactors can also be 
transported via the TAT pathway. [2, 3]  
 
TAT pathway signal peptides have a tripartite structure 
comprising a charged amino terminus (N-region), a 
hydrophobic central core (H-region), and a cleavage site 
containing the carboxy terminus (C-region). There are several 
distinct differences between TAT and Sec-dependent signal 
sequences, the most notable of which is the presence of a 
characteristic sequence motif, (S/T)-R-R-x-F-L-K, at the N/H-
region boundary. The twin arginine residues of the motif are 
probably invariant, while the other residues occur at a 
frequency of greater than 50%. [2] The initial residue of the 
motif may act as an N-cap for α-helix formation by the H-
region, since a potentially helix-breaking praline is often 
present at the end of the H-region. [4] The C-region is 
characterised by a high proportion of basic amino acids [3], 
while the Sec-dependent pathway is biased against positively 
charged residues near to the signal peptidase cleavage site. [5] 
There is also a significant size difference: an extended N-
region gives TAT signal peptides an average length that is 14 
amino acids longer than that of Sec signal peptides. In 
addition, a greater frequency of glycine and threonine, 
and a lower abundance of leucine residues, is observed in 
the H-region, giving rise to a significant decrease in its 
hydrophobicity. [4]  
 
Secreted or surface-expressed proteins are open to direct 
surveillance by the immune system, and are thus of 
potential interest as vaccine candidates. Identification of 
such proteins is a vital component in the rational discovery 
of vaccines. In order to predict, in silico, the subcellular 
location of bacterial proteins, one must consider the export 
of proteins by all possible pathways, including the TAT 
secretion system. Currently, the only available Web-server 
for the prediction of TAT signal sequences is TATP. [6] 
The method is not generic and requires specific tailoring for 
each genome. A simpler method for identifying TAT signal 
sequences is the well known TAT motif [1, 2]: this consists 
of the conserved residues described above, followed by a 
hydrophobic stretch of residues. Such methods have 
limitations as they allow only a small variation within the 
TAT signal sequence. In response to this limitation, we 
have developed a rapid, yet accurate alternative: TATPred. 
TATPred uses a Bayesian methodology to characterise and 
predict TAT signal peptides. 
 
Methodology: 
To train the method, we used data-sets of TAT 
translocated proteins and proteins not translocated by 
TAT yet which still contain a twin arginine motif. Based 
on annotations, proteins with an N-terminal RR motif 
were extracted from Swiss-Prot release 42: 117 TAT - 
translocated (positive set) and 1178 non-TAT 
translocated (negative set). Only proteins which were 
designated as “TAT translocated” were accepted for the 
positive set. Non-TAT translocated proteins were of 
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cytoplasmic or membraneous subcellular location or were 
translocated via different export pathways. In all cases, only 
confirmed annotations were accepted. All entries with 
relevant annotations containing “hypothetical” or “putative” 
or “possible” or “putative” were excluded. 
 
It is common practice to use non-redundant test and training 
data-sets by removing similar sequences. However, one could 
not remove redundancy within the TAT translocated set as it 
was too small. Instead, a separate set of proteins, not used in 
testing, was used to assess the method. Of the 117 putative 
TAT translocated proteins, 12 had experimental evidence 
confirming that they were transported via the TAT system. To 
form a test-set of confirmed TAT-translocated proteins, these 
12 sequences were removed from the training set.  To 
increase the size of the test-set, 23 other TAT translocated 
proteins from an annotated E. coli set 
(www.jic.bbsrc.ac.uk/staff/tracy-plamer/signals.htm) were 
added. This test-set was also used to assess the predictive 
ability of TatP. The non-redundant non-TAT translocated 
protein set comprised 714 proteins. The second negative test-
set, which was only used in testing, comprised Sec-
dependent/Type II signal peptides. This was taken from the 
SignalP v2 data-set [7], and contained 250 bacterial proteins. 
This set is referred to as the signal set hereafter. 
 
A sequence model was developed which used the invariant 
twin arginines as a reference point. Models were selected with 
lengths of 3 to 22 residues. A comprehensive range of 
models was tested, with 1 to 10 residues on either side of 
the twin arginines. Each model was used to train a 
Naïve-Bayesian Network (BN) with a structure such that 
one input node was used for each residue, while the one 
output node could take the values of TAT or non-TAT. 
This approach required the creation of 110 BNs. To train 
the BNs on the negative data-set, a random residue was 
selected from within the first 50 residues of each protein 
in the negative training set.  
 
On completion of network training, query sequences 
were processed as follows: the first 50 residues of the 
query sequence were scanned to identify the presence of 
consecutive arginines. When two such arginines were 
found, appropriate sequences for the specific network 
were extracted. The residues were entered into the input 
nodes of the BN, with the first residue of the extracted 
sub-sequence being entered into node one, the second 
into node two, etc. The BN assesses whether or not the 
query sub-sequence is an instance of a TAT signal 
sequence and also returns an associated probability 
(threshold for a positive score is 80%). Testing was 
conducted on both the negative and positive data-sets 
using five-fold cross-validation; overall accuracy was 
obtained by averaging the five values. The signal set was 
then tested using the same methodology. 
 
 
Start         
Position 
End 
Position 
Model 
Length 
Sensitivity Specificity 
-10 10 22 0.809 0.968 
-9 9 20 0.830 0.960 
-8 8 18 0.872 0.964 
-7 7 16 0.894 0.953 
-6 6 14 0.915 0.931 
-5 5 12 0.957 0.939 
-4 4 10 0.957 0.939 
-3 3 8 0.957 0.939 
-2 2 6 1.000 0.903 
-1 1 4 1.000 0.885 
0 0 2 1.000 0.833 
-1 3 5 0.943 0.942 
Table 1: Representative sample of results for the 110 networks used to develop TATPred. The best performing network is 
shown in bold 
 
Method Sensitivity Specificity Signal 
Sequence 
Accuracy (%) 
TATP 0.914 0.981 96.4 
TAT Motif 0.743 1.000 100.0 
TATPred 0.943 0.942 100.0 
Table 2: Representative sample of results for the 110 networks used to develop TATPred when tested using the signal set 
 
 
 
 
 
Results and Discussion: 
Performance of different sequence lengths 
When tested using the test-set and the non-TAT 
translocated set, the 110 sequence models investigated 
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produced significantly different results, of which an 
informative sample is shown in Table 1. The best performing 
network, which comprises one residue before the twin 
arginines and the two residues after them, has a high degree of 
sensitivity and specificity (0.943 and 0.942 respectively). 
Only two from the test set were not predicted as TAT-
translocated: YEDY_ECOLI and YCBK_ECOLI. 
 
The best performing model considers only 5 residues. While 
remarkably small, it reaffirms previous studies indicating 
residue conservation close to the twin arginines. Differences 
in prediction accuracy reflect the ability of Bayesian methods 
to account for sequence variability. The BNs provide a 
probabilistic classification of which residues at which 
positions are likely to be consistent with a TAT signal 
sequence. 
 
There is a correlation between the number of residues in a 
sequence model prior to the twin arginine motif and the 
sensitivity of prediction: the greater the number, the lower the 
concomitant sensitivity. This confirms previous studies 
showing residues prior to the twin arginine motif (with the 
exception of those immediately before) are not conserved. 
Sequence models with a high proportion of residues after the 
twin arginine motif show a higher specificity of prediction, 
though this is not as marked as the low specificity described 
above. This trend is clearly apparent in Table 1. The -10 +2 
model, for example, has a prediction sensitivity of 0.254, 
while the -2 +10 mode has a sensitivity of 0.867.  
 
Performance of different sequence lengths in the signal 
test-set 
Assessment of the ability of the 110 sequence models to 
discriminate between TAT-translocated proteins and Sec 
signal sequences were performed using the Signal dataset. 
The -1 +3 sequence model, which performed best previously 
(see Table 1), also had the highest sensitivity of prediction; it 
correctly identified all the dataset as non-TAT translocated. 
Networks with significant proportions of their corresponding 
sequence model located after the twin arginine motif could 
not distinguish between TAT-translocated proteins and those 
possessing a Sec signal sequence.  Higher specificity may be 
due to the sequence models also considering the hydrophobic 
region in the TAT signal sequence. Prediction accuracy for 
the signal set for these networks tends to be lower, as these 
networks are not able to distinguish the hydrophobic region 
on the TAT-signal peptide from the hydrophobic region of a 
Sec signal peptide.  
 
Comparison of performance with other TAT-signal 
sequence prediction methods 
Compared to other methods for the detection of TAT-
translocated proteins, increased accuracy is seen over both 
simple motif methods and the TATP algorithm. The results of 
the comparison are shown in Table 2. As Table 2 shows, 
TATPred achieves a higher sensitivity of prediction than the 
two publicly available methods. Specificity of prediction is 
marginally lower than the other two methods. Strikingly, 
TATPred correctly identifies all the Signal dataset as being 
non-TAT translocated, despite 36 of the proteins 
possessing a twin arginine motif. 
   
Differences in accuracy between the three prediction 
methods can be explained by differences in 
methodology. As with all regular-expression-based 
methods, the motifs cannot account for variation within 
TAT signal sequences, and thus only distinguish the 
most typical TAT-translocated proteins. TATP is a more 
sophisticated and accurate predictor, yet it is partially 
dependent on a motif to determine TAT signal peptides. 
The rigidity of a sequence motif may explain why it 
correctly identifies less of the test set. By contrast, 
TATPred exhibits high sensitivity for a range of 
organisms. Its Bayesian-based sequence model 
methodology offers a more flexible probabilistic 
approach that allows it to identify more variant TAT 
signal peptide sequences. 
 
The specificity of TATPred is marginally lower than the 
other methods. The flexibility of TAT signal-sequence 
recognition, which confers high sensitivity, causes a 
slightly higher rate of false-positive predictions. A high 
sensitivity ensures that more candidate proteins are 
identified; false positives can then be screened out using 
other prediction methods. This is of particular 
importance in the area of target discovery, where it is 
vitally important to identify all possible targets. 
Algorithms, such as TATPred, could thus form a 
valuable part of multi-algorithmic approaches to the 
accurate prediction of subcellular location. 
 
Conclusion:  
TATPred deals with large, genomic-scale data-sets with 
high sensitivity and specificity of prediction. The method 
allows rapid analysis and identification of TAT signal 
sequences. Only proteins that are exposed on the surface 
of the pathogen will be accessible to surveillance by the 
immune system and hence produce a protective response. 
The computational identification of subcellular location 
can thus be used to screen pathogen genomes for 
surface-exposed proteins and greatly reduce the number 
of candidates that require in vitro testing. [8] An in silico 
analysis of the pathogen genome may mean that more 
vaccine candidates could be identified, allowing the 
development of vaccines for pathogens that have 
previously proved difficult to develop using conventional 
vaccinology techniques. Screening of pathogen genomes 
to identify such proteins can increase the efficiency of 
vaccine or drug discovery, reducing the development 
time and cost of new therapies. There are many freely 
available algorithms that facilitate reverse vaccinology 
[9, 10]; TATPred is a potentially useful new approach 
which can complement such approaches. 
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